Browse > Article
http://dx.doi.org/10.5090/kjtcs.2010.43.3.273

Superior Vena Cava Resection and Reconstruction in Thoracic Malignancy  

Han, Kook-Nam (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Kang, Chang-Hyun (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Kim, Young-Tae (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Jheon, Sang-Hoon (Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital)
Sung, Sook-Whan (Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital)
Kim, Joo-Hyun (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
Publication Information
Journal of Chest Surgery / v.43, no.3, 2010 , pp. 273-279 More about this Journal
Abstract
Background: The benefit of superior vena cava (SVC) resection in thoracic malignancies remains controversial. We analyzed the results of extended resection in patients with thoracic malignancy involving the SVC. Material and Method: From March 2000 to March 2009, we performed surgical resection and reconstruction in 18 thoracic malignancies involving the SVC. Ten male and 8 female enrolled and their mean age was 56 years. Result: SVC reconstruction was performed in 9 patients with polytetrafluoroethylene (PTFE) graft. Primary closure was possible in 6 patients by partially clamping the SVC. Patch angioplasty was performed in 3 patients with PTFE or autologous pericardial patch. Three-year survival was 58.0% and median survival time was 24.5 months. Disease specific survival and recurrence free survival were not significantly different between lung cancer and mediastinal malignancy. Obstruction of graft was detected in 4 patients during follow-up; SVC graft obstruction in 1 patient, and accessory graft between the innominate vein and right atrium in 3 patients. Conclusion: Extended resection of thoracic malignancies involving the SVC was a feasible method in selected patients. Although the morbidity rate was relatively high, mid-term survival was acceptable when complete resection was possible.
Keywords
Lung neoplasms; Mediastinal neoplasms; Great vessels;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Goldstraw P. Selection of patients for surgery after induction chemotherapy for N2 non-small-cell lung cancer. J Clin Oncol 2006;24:3317-8   DOI   ScienceOn
2 Larsson S, Lepore V. Technical options in reconstruction of large mediastinal veins. Surgery 1992;111:311-7   PUBMED
3 Kuzo RS, Pooley RA, Crook JE, et al. Measurement of caval blood flow with MRI during respiratory maneuvers: implications for vascular contrast opacification on pulmonary CT angiographic studies. AJR 2007;188:839-42   DOI   ScienceOn
4 Dartevelle P, Macchiarini P, Chapelier A. Technique of superior vena cava resection and reconstruction. Chest Surg Clin N Am 1995;5:345-58   PUBMED
5 Spaggiari L, Leo F, Veronesi G, et al. Superior vena cava resection for lung and mediastinal malignancies: a singlecenter experience with 70 cases. Ann Thorac Surg 2007;83:223-30   DOI   ScienceOn
6 Grunenwald DH. Surgery for advanced stage lung cancer. Semin Surg Oncol 2000;18:137-42   DOI   PUBMED   ScienceOn
7 Suntharalingam M, Sonett JR, Haas ML, et al. The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors. Cancer J 2000;6:365-71   PUBMED
8 Tsuchiya R, Asamura H, Kondo H, et al. Extended resection of the left atrium, great vessels, or both for lung cancer. Ann Thorac Surg 1994;57:960-5   DOI   PUBMED   ScienceOn
9 Picquet J, Blin V, Dussaussoy C, et al. Surgical reconstruction of the superior vena cava system: indications and results. Surgery 2009;145:93-9   DOI   ScienceOn
10 Spaggiari L, Regnard JF, Magdeleinat P, et al. Extended resections for bronchogenic carcinoma invading the superior vena cava system. Ann Thorac Surg 2000;69:233-6   DOI   ScienceOn
11 Rendina EA, Venuta F, De Giacomo T, et al. Induction chemotherapy for T4 centrally located non-small cell lung cancer. J Thorac Cardiovasc Surg 1999;117:225-33   DOI   ScienceOn
12 Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009;361:1368-75   DOI   ScienceOn
13 Bernard A, Bouchot O, Hagry O, et al. Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer. Eur J Cardiothorac Surg 2001;20:344-9   DOI   ScienceOn
14 Weinreb JC, Mootz A, Cohen JM. MRI evaluation of mediastinal and thoracic inlet venous obstruction. AJR 1986;146:679-84   DOI   ScienceOn
15 Spaggiari L, Veronesi G, D'Aiuto M, et al. Superior vena cava reconstruction using heterologous pericardial tube after extended resection for lung cancer. Eur J Cardiothorac Surg 2004;26:649-51   DOI   ScienceOn
16 Dartevelle P, Chapelier A, Navajas M. Replacement of the superior vena cava with polytetrafluoroethylene grafts combined with resection of mediastinal pulmonary malignant tumors. Report of thirteen cases. J Thorac Cardiovasc Surg 1987;94:361-6   PUBMED
17 Spaggiari L, Thomas P, Magdeleinat P, et al. Superior vena cava resection with prosthetic replacement for non-small cell lung cancer: Long-term results of a multicentric study. Eur J Cardiothorac Surg 2002;21:1080-6   DOI   ScienceOn
18 Dartevelle PG. Extended operations for the treatment of lung cancer. Ann Thorac Surg 1997;63:12-9   DOI   PUBMED   ScienceOn
19 Turkmen C, Sonmezoglu K, Toker A, et al. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med 2007;32:607-12   DOI   ScienceOn
20 Shargall Y, De Perrot M, Keshavjee S, et al. 15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer. Lung Cancer 2004;45:357-63   DOI   ScienceOn